Tradestie Institutional Equity Comparison Engine
ECG vs CDNL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ECG Overall Edge
ECG Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Everus Construction Group, Inc. (ECG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ECG trades at 10.8x Forward P/E with 8.2% operating margin (+40.3% YoY revenue) versus CDNL at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ECG sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against CDNL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ECG
ECG 10.8x vs CDNL N/M Fwd P/E
Growth & Margin Winner
ECG
Op Margin 8.2% vs N/A ยท YoY +40.3% vs N/A
Momentum & Technical Winner
ECG
1Y -9.5% vs -79.6% ยท 52W Pos 6% vs 0%
Options & Structure Winner
ECG
BREAKDOWN (6th %ile IV) vs UNCLASSIFIED (N/A IV)
ECG
NYSE
Everus Construction Group, Inc.
Operative Builders
$76.59
-8.66% 1D
Market Cap
$4.3B
1M Return
-21.08%
1Y Return
-9.5%
Forward P/E
10.8x
Unified AI Score
50.0 / 100
HOLD
Tech 73.0
Fund 64.0
Flow 55.0
Mom 64.0
CDNL
US Equity
CDNL
Institutional Equity
$4.75
-8.4% 1D
Market Cap
N/A
1M Return
-65.34%
1Y Return
-79.57%
Forward P/E
N/M
Unified AI Score
44.2 / 100
HOLD
Tech 45.0
Fund 42.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ECG -9.5%
CDNL -79.57%
Spread: +61.76 pp (ECG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ECG TTM Op. Margin: 8.2%
CDNL TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECG vs CDNL. Trailing 12-month operating profitability (ECG 8.2% vs CDNL N/A) and valuation multiples (ECG 10.8x vs CDNL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECG | CDNL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.3B | N/A | Larger Scale | ECG |
| Trailing P/E Ratio Valuation | 15.1x | N/M | Lower Multiple | ECG |
| Forward P/E Ratio Valuation | 10.8x | N/M | Lower Multiple | ECG |
| Revenue Growth (YoY) Growth | +40.3% | N/A | Higher Growth | ECG |
| Operating Margin (TTM) Profitability | 8.2% | N/A | Higher Margin | ECG |
| Net Profit Margin Profitability | 6.2% | N/A | Higher Margin | ECG |
| Return on Equity (ROE) Capital Efficiency | 40.3% | N/A | Higher ROE | ECG |
| 52-Week Range Position Momentum | 6% ($70โ$172) | 0% ($5โ$96) | Stronger Trend | ECG |
| Beta / 30D Volatility Risk Regime | 2.17ฮฒ ยท 127% Vol | 2.65ฮฒ ยท 238% Vol | Lower Realized Risk | ECG |
| Unified Institutional Score Composite Signal | 50.0 / 100 (HOLD) | 44.2 / 100 (HOLD) | Higher Composite | ECG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ECG vs CDNL Buy Guide
ECG
BREAKDOWN
138d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
CDNL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ECG nor CDNL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.